We think Ingersoll Rand is on solid financial footing. The company ended 2024 with a net leverage ratio of around 1.6 times adjusted EBITDA, and debt maturities are well spread out. At the time of the ...

Highlights Sales increased 2% to $10.6 billion, in-line with global light vehicle productionDiluted earnings per share of ...

Bio-Rad projects 2025 currency-neutral revenue growth of 1.5%-3.5%, excluding contributions from acquisitions. Diagnostics revenue is expected to grow between 2%-3%, while Life Science revenue is ...

Increased local autonomy, more complex operations ... from the school business management profession, but also with head teachers and governors. The work on drafting the standards will begin in 2015, ...

Roche Holding AG Akt 1.04% CHF232.83B ...